PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337608
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337608
Endoscopic Submucosal Dissection Market Size and Share Analysis by Product, Indication, End User - Global Industry Demand Forecast to 2030
The endoscopic submucosal dissection market will USD 512.9 million by 2030, exhibiting a CAGR of 5.5% during the forecast period. This is ascribed to the increasing occurrence of diseases as well as use of endoscopies for disease detection and diagnose, and rising population.
Stomach cancers have been a main problem, with its occurrence to ordinarily linked to nutritional factors along with the intake of salted and pickled foods. In the U.S., stomach cancers are a leading cause of loss of life, accounting for nearly 2% of all new cancers annually.
Similarly, the U.K. attributes around 5 out of a 100 cases of stomach cancers to obesity. In Japan, a national endoscopic surveillance program is performed to fight the excessive chances of stomach cancers, emphasizing ordinary screening via endoscopy and double-contrast barium X-ray.
The surgical knives used in ESD tactics is experiencing rapid growth, with a CAGR of approx.6.5% in the forecast period. This growth can be attributed to the evolving variety of surgical knives that provide more desirable efficacy, safety, and cost-effectiveness. These knives are designed for resecting different-kind types of tissues, allowing surgeons to carry out unique and targeted removals.
Additionally, advancements in technology, along with robot surgical treatment and telesurgery, have in addition contributed to the surge in surgical knife income, permitting more minimally hostile procedures with decreased headaches and enhanced affected person consequences.
APAC holds a significant share of approximately 25% in the endoscopic submucosal dissection market due to the excessive occurrence of gastric and esophageal cancers. China, particularly, ranks among the top countries in terms of the occurrence of those cancers, prompting the government to arrange complete screening packages and preventive initiatives.
Europe accounts for approx. 30% in the industry, with a rising incidence of chronic diseases and a shift in the direction of minimally invasive surgeries. Gastrointestinal diseases, which include peptic ulcers, colon polyps, and colorectal cancers, are widely wide-spread in Western European countries.
Endoscopy-guided minimally invasive surgeries provide advantages over traditional approaches, which includes faster restoration, reduced ache, and lower risk of complications. The enlargement of hospitals and ambulatory surgical facilities (ASCs) in Europe has further facilitated the adoption of endoscopic procedures.
Hospitals have embraced ESD procedure, retaining a substantial percentage of 60% in 2022, due to their much less invasive nature. Recent improvements have made ESD accessible in various healthcare centers globally.
Similarly, KMC Hospital in India appropriately accomplished an endoscopic process to remove massive belly tumour through the mouth, avoiding the need for outside scars or traditional surgical procedure.
It is because of the increasing incidence of targeted diseases all over the world, the demand for endoscopic submucosal dissection will rise in the years to come
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by indication
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
- 6.1. Market Dynamics
- 6.1.1. Trends
- 6.1.2. Drivers
- 6.1.3. Restraints/challenges
- 6.1.4. Impact analysis of drivers/restraints
- 6.2. Impact of COVID-19
- 6.3. Porter's Five Forces Analysis
- 6.3.1. Bargaining power of buyers
- 6.3.2. Bargaining power of suppliers
- 6.3.3. Threat of new entrants
- 6.3.4. Intensity of rivalry
- 6.3.5. Threat of substitutes
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Indication (2017-2030)
- 7.4. Market Revenue, by End User (2017-2030)
- 7.5. Market Revenue, by Region (2017-2030)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Indication (2017-2030)
- 8.4. Market Revenue, by End User (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Indication (2017-2030)
- 9.4. Market Revenue, by End User (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. APAC Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Indication (2017-2030)
- 10.4. Market Revenue, by End User (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. LATAM Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Indication (2017-2030)
- 11.4. Market Revenue, by End User (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. MEA Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Indication (2017-2030)
- 12.4. Market Revenue, by End User (2017-2030)
- 12.5. Market Revenue, by Country (2017-2030)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Indication (2017-2030)
- 13.4. Market Revenue, by End User (2017-2030)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Indication (2017-2030)
- 14.4. Market Revenue, by End User (2017-2030)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Indication (2017-2030)
- 15.4. Market Revenue, by End User (2017-2030)
Chapter 16. France Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Indication (2017-2030)
- 16.4. Market Revenue, by End User (2017-2030)
Chapter 17. U.K. Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Indication (2017-2030)
- 17.4. Market Revenue, by End User (2017-2030)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Indication (2017-2030)
- 18.4. Market Revenue, by End User (2017-2030)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Indication (2017-2030)
- 19.4. Market Revenue, by End User (2017-2030)
Chapter 20. Japan Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Indication (2017-2030)
- 20.4. Market Revenue, by End User (2017-2030)
Chapter 21. China Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Indication (2017-2030)
- 21.4. Market Revenue, by End User (2017-2030)
Chapter 22. India Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Indication (2017-2030)
- 22.4. Market Revenue, by End User (2017-2030)
Chapter 23. Australia Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Indication (2017-2030)
- 23.4. Market Revenue, by End User (2017-2030)
Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Indication (2017-2030)
- 24.4. Market Revenue, by End User (2017-2030)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Indication (2017-2030)
- 25.4. Market Revenue, by End User (2017-2030)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Indication (2017-2030)
- 26.4. Market Revenue, by End User (2017-2030)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Indication (2017-2030)
- 27.4. Market Revenue, by End User (2017-2030)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Indication (2017-2030)
- 28.4. Market Revenue, by End User (2017-2030)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Market Revenue, by Product (2017-2030)
- 29.3. Market Revenue, by Indication (2017-2030)
- 29.4. Market Revenue, by End User (2017-2030)
Chapter 30. Competitive Landscape
- 30.1. List of Market Players and their Offerings
- 30.2. Competitive Benchmarking of Key Players
- 30.3. Product Benchmarking of Key Players
- 30.4. Recent Strategic Developments
Chapter 31. Company Profiles
- 31.1. Olympus Corporation
- 31.1.1. Business overview
- 31.1.2. Product and service offerings
- 31.1.3. Key financial summary
- 31.2. Boston Scientific Corporation
- 31.2.1. Business overview
- 31.2.2. Product and service offerings
- 31.2.3. Key financial summary
- 31.3. FUJIFILM Holdings Corporation
- 31.3.1. Business overview
- 31.3.2. Product and service offerings
- 31.3.3. Key financial summary
- 31.4. Sumitomo Bakelite Co. Ltd.
- 31.4.1. Business overview
- 31.4.2. Product and service offerings
- 31.4.3. Key financial summary
- 31.5. Creo Medical Group plc
- 31.5.1. Business overview
- 31.5.2. Product and service offerings
- 31.5.3. Key financial summary
- 31.6. MTW-Endoskopie W.Haag KG
- 31.6.1. Business overview
- 31.6.2. Product and service offerings
- 31.7. Ovesco Endoscopy AG
- 31.7.1. Business overview
- 31.7.2. Product and service offerings
- 31.8. KARL STORZ SE & Co. KG
- 31.8.1. Business overview
- 31.8.2. Product and service offerings
- 31.9. CONMED Corporation
- 31.9.1. Business overview
- 31.9.2. Product and service offerings
- 31.9.3. Key financial summary
- 31.10. MICRO-TECH (Nanjing) Co. Ltd.
- 31.10.1. Business overview
- 31.10.2. Product and service offerings
- 31.11. Medtronic plc
- 31.11.1. Business overview
- 31.11.2. Product and service offerings
- 31.11.3. Key financial summary
- 31.12. HOYA Corporation
- 31.12.1. Business overview
- 31.12.2. Product and service offerings
- 31.12.3. Key financial summary
- 31.13. STERIS plc
- 31.13.1. Business overview
- 31.13.2. Product and service offerings
- 31.13.3. Key financial summary
- 31.14. Cook Group Incorporated
- 31.14.1. Business overview
- 31.14.2. Product and service offerings
- 31.15. Leo Medical Co. Ltd.
- 31.15.1. Business overview
- 31.15.2. Product and service offerings
Chapter 32. Appendix
- 32.1. Abbreviations
- 32.2. Sources and References
- 32.3. Related Reports
